Search Browse Earnings

Perspective Therapeutics, Inc. — SlamSEC

Perspective Therapeutics, Inc.

NYSE:CATX

Pharmaceutical Preparations·SEATTLE, WA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$2.4M

+3.0% YoY

FY 2022

Adj. EBITDA

-$40.0M

-1676.0% margin

FY 2024

Net Income

-$46.5M

-1950.8% margin

FY 2024

EPS (Diluted)

-$1.74

FY 2024

Stock Price

$5.22

-2.4%

2026-03-11

52W Range

$1.60 – $6.16

P/E Ratio

-3.0x

Market Cap

$388.0M

Cash

$9.2M

FY 2024

Total Debt

$1.7M

FY 2024

Net Cash

$7.5M

FY 2024

Enterprise Value

$380.5M

Debt / EBITDA

0.2x

FY 2022

EV / EBITDA

-9.5x

Employees

—